Thérèse Keravis

1.8k total citations
34 papers, 1.5k citations indexed

About

Thérèse Keravis is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Thérèse Keravis has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pharmacology. Recurrent topics in Thérèse Keravis's work include Phosphodiesterase function and regulation (22 papers), Renin-Angiotensin System Studies (9 papers) and Nitric Oxide and Endothelin Effects (7 papers). Thérèse Keravis is often cited by papers focused on Phosphodiesterase function and regulation (22 papers), Renin-Angiotensin System Studies (9 papers) and Nitric Oxide and Endothelin Effects (7 papers). Thérèse Keravis collaborates with scholars based in France, Canada and United States. Thérèse Keravis's co-authors include Claire Lugnier, Laure Favot, Abdurazzag Abusnina, Jean‐Claude Stoclet, Christian Bronner, Issaka Yougbaré, Alain Le Bec, Ramaroson Andriantsitohaina, Jack N. Wells and Narcisse Komas and has published in prestigious journals such as PLoS ONE, Biochemistry and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Thérèse Keravis

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thérèse Keravis France 22 1.0k 290 273 237 189 34 1.5k
Chang-Ping Hu China 27 582 0.6× 176 0.6× 203 0.7× 187 0.8× 103 0.5× 60 1.6k
Françoise Martin‐Nizard France 18 636 0.6× 178 0.6× 175 0.6× 249 1.1× 83 0.4× 34 1.2k
Chang‐Hui Liao Taiwan 25 661 0.6× 235 0.8× 139 0.5× 86 0.4× 235 1.2× 67 1.5k
Laura Caparrotta Italy 20 738 0.7× 106 0.4× 194 0.7× 214 0.9× 168 0.9× 76 1.5k
Yong Pan China 20 920 0.9× 153 0.5× 314 1.2× 506 2.1× 143 0.8× 40 2.1k
Yan‐Jun Xu Canada 21 630 0.6× 83 0.3× 362 1.3× 222 0.9× 67 0.4× 52 1.5k
Serena Viappiani Italy 14 304 0.3× 119 0.4× 142 0.5× 215 0.9× 205 1.1× 21 1.3k
Zhou‐Yan Bian China 31 1.1k 1.1× 163 0.6× 739 2.7× 172 0.7× 67 0.4× 63 2.2k
Lan Sun China 25 598 0.6× 132 0.5× 215 0.8× 208 0.9× 52 0.3× 66 1.6k

Countries citing papers authored by Thérèse Keravis

Since Specialization
Citations

This map shows the geographic impact of Thérèse Keravis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thérèse Keravis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thérèse Keravis more than expected).

Fields of papers citing papers by Thérèse Keravis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thérèse Keravis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thérèse Keravis. The network helps show where Thérèse Keravis may publish in the future.

Co-authorship network of co-authors of Thérèse Keravis

This figure shows the co-authorship network connecting the top 25 collaborators of Thérèse Keravis. A scholar is included among the top collaborators of Thérèse Keravis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thérèse Keravis. Thérèse Keravis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yougbaré, Issaka, Thérèse Keravis, & Claire Lugnier. (2020). NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(3). 166019–166019. 12 indexed citations
2.
Yougbaré, Issaka, Caroline Morin, Abdurazzag Abusnina, et al.. (2020). NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants. Frontiers in Pharmacology. 11. 1266–1266. 10 indexed citations
3.
Keravis, Thérèse, Laure Favot, Raffaella Soleti, et al.. (2015). Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells. PLoS ONE. 10(12). e0145291–e0145291. 28 indexed citations
4.
Yougbaré, Issaka, Thérèse Keravis, Abdurazzag Abusnina, et al.. (2014). Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(7). 916–926. 7 indexed citations
5.
Abusnina, Abdurazzag, et al.. (2014). Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition. Thrombosis and Haemostasis. 113(2). 319–328. 36 indexed citations
6.
Keravis, Thérèse, Fanny Monneaux, Issaka Yougbaré, et al.. (2012). Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor. PLoS ONE. 7(1). e28899–e28899. 26 indexed citations
7.
Abusnina, Abdurazzag, Thérèse Keravis, Issaka Yougbaré, Christian Bronner, & Claire Lugnier. (2011). Anti‐proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Molecular Nutrition & Food Research. 55(11). 1677–1689. 91 indexed citations
8.
Keravis, Thérèse & Claire Lugnier. (2010). Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs. Current Pharmaceutical Design. 16(9). 1114–1125. 55 indexed citations
9.
Abusnina, Abdurazzag, Mahmoud Alhosin, Thérèse Keravis, et al.. (2010). Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis. Cellular Signalling. 23(1). 152–160. 68 indexed citations
10.
11.
Keravis, Thérèse, et al.. (2009). PDEs1‐5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization. International Journal of Experimental Pathology. 90(6). 605–614. 9 indexed citations
12.
Campos‐Toimil, Manuel, Thérèse Keravis, Francisco Orallo, K. Takeda, & Claire Lugnier. (2008). Short‐term or long‐term treatments with a phosphodiesterase‐4 (PDE4) inhibitor result in opposing agonist‐induced Ca2+ responses in endothelial cells. British Journal of Pharmacology. 154(1). 82–92. 43 indexed citations
13.
Keravis, Thérèse, et al.. (2005). Assessment of Phosphodiesterase Isozyme Contribution in Cell and Tissue Extracts. Humana Press eBooks. 307. 63–74. 21 indexed citations
14.
Favot, Laure, Thérèse Keravis, & Claire Lugnier. (2004). Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4. Thrombosis and Haemostasis. 92(9). 634–645. 48 indexed citations
15.
Favot, Laure, Sophie Martin, Thérèse Keravis, Ramaroson Andriantsitohaina, & Claire Lugnier. (2003). Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovascular Research. 59(2). 479–487. 77 indexed citations
16.
Favot, Laure, Thérèse Keravis, Vincent Holl, Alain Le Bec, & Claire Lugnier. (2003). VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thrombosis and Haemostasis. 90(8). 334–343. 86 indexed citations
17.
Keravis, Thérèse, Narcisse Komas, & Claire Lugnier. (2000). Cyclic Nucleotide Hydrolysis in Bovine Aortic Endothelial Cells in Culture: Differential Regulation in Cobblestone and Spindle Phenotypes. Journal of Vascular Research. 37(4). 235–249. 28 indexed citations
18.
Lugnier, Claire, et al.. (1999). Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei. Biochimica et Biophysica Acta (BBA) - General Subjects. 1472(3). 431–446. 51 indexed citations
19.
Keravis, Thérèse, et al.. (1999). Effect of pre‐exposure to vasoconstrictors on isoprenaline‐induced relaxation in rat aorta: involvement of inducible nitric oxide synthase. British Journal of Pharmacology. 128(3). 591–596. 5 indexed citations
20.
Gerzer, R., et al.. (1988). Discrepancy between effects of cholera toxin on net fluid movement and cAMP levels in rat jejunum, ileum, and colon. Digestive Diseases and Sciences. 33(9). 1153–1158. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang-Ping Hu Breakdown of academic impact, for papers by Françoise Martin‐Nizard Breakdown of academic impact, for papers by Chang‐Hui Liao Breakdown of academic impact, for papers by Laura Caparrotta Breakdown of academic impact, for papers by Yong Pan Breakdown of academic impact, for papers by Yan‐Jun Xu Breakdown of academic impact, for papers by Serena Viappiani Breakdown of academic impact, for papers by Zhou‐Yan Bian Breakdown of academic impact, for papers by Lan Sun
Rankless by CCL
2026